Compounds > pyridostigmine bromide
Page last updated: 2024-08-18

pyridostigmine bromide and Cardiomegaly

pyridostigmine bromide has been researched along with Cardiomegaly in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, LN; He, X; Liu, JJ; Liu, LZ; Lu, Y; Sun, L; Yu, XJ; Zang, WJ; Zhao, M1
Biondi, B; Cittadini, A; Colao, A; Fazio, S; Lombardi, G; Merola, B; Sabatini, D; Saccà, L; Santomauro, M1

Other Studies

2 other study(ies) available for pyridostigmine bromide and Cardiomegaly

ArticleYear
Long-term administration of pyridostigmine attenuates pressure overload-induced cardiac hypertrophy by inhibiting calcineurin signalling.
    Journal of cellular and molecular medicine, 2017, Volume: 21, Issue:9

    Topics: Animals; Calcineurin; Cardiomegaly; GATA4 Transcription Factor; Heart Function Tests; Hemodynamics; Male; NFATC Transcription Factors; ORAI1 Protein; Pressure; Protein Binding; Pyridostigmine Bromide; Rats, Sprague-Dawley; Signal Transduction; Stromal Interaction Molecule 1; Time Factors; Vagus Nerve

2017
[Cardiac effects of GH].
    Minerva endocrinologica, 1993, Volume: 18, Issue:3 Suppl 1

    Topics: Acromegaly; Adult; Cardiomegaly; Clonidine; Echocardiography, Doppler; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Heart Ventricles; Humans; Hypertension; Insulin-Like Growth Factor I; Male; Middle Aged; Pyridostigmine Bromide; Stroke Volume; Ventricular Function, Left

1993